Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Author:

Miloslavsky E. M.1,Specks U.2,Merkel P. A.3,Seo P.4,Spiera R.5,Langford C. A.6,Hoffman G. S.6,Kallenberg C. G. M.7,St.Clair E. W.8,Tchao N. K.9,Viviano L.10,Ding L.10,Sejismundo L. P.4,Mieras K.2,Iklé D.11,Jepson B.11,Mueller M.12,Brunetta P.13,Allen N. B.8,Fervenza F. C.2,Geetha D.4,Keogh K.2,Kissin E. Y.14,Monach P. A.14,Peikert T.2,Stegeman C.7,Ytterberg S. R.2,Stone J. H.1,

Affiliation:

1. Massachusetts General Hospital; Boston

2. Mayo Clinic, Rochester; Minnesota

3. University of Pennsylvania School of Medicine; Philadelphia

4. Johns Hopkins University; Baltimore Maryland

5. Hospital for Special Surgery; New York New York

6. Cleveland Clinic; Cleveland Ohio

7. University of Groningen and University Medical Center Groningen; Groningen The Netherlands

8. Duke University Medical Center; Durham North Carolina

9. Immune Tolerance Network; South San Francisco California

10. National Institute of Allergy and Infectious Diseases, NIH; Bethesda Maryland

11. Rho; Chapel Hill North Carolina

12. FDA; Silver Spring Maryland

13. Genentech; South San Francisco California

14. Boston University School of Medicine; Boston Massachusetts

Funder

Immune Tolerance Network

University of California San Francisco

NIH (National Institute of Allergy and Infectious Diseases)

Juvenile Diabetes Research Foundation

Genentech and Biogen Idec provided the study medications and partial funding for the RAVE trial

Mayo Clinic

Johns Hopkins University

Boston University School of Medicine

NIH (Mayo Clinic: National Center for Research Resources Clinical and Translational Science award)

Johns Hopkins University: National Center for Research Resources Clinical and Translational Science

Boston University: National Center for Research Resources Clinical and Translational Science award

Genentech (Clinical Immunology Fellowship)

Arthritis Foundation (Arthritis Investigator Award)

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3